Literature DB >> 23983374

Xiao-Chai-Hu Tang in treating model mice with D-galactosamine-induced liver injury.

Yun-Xiao Zhou1, Yun-Qing Qiu, Li-Qian Xu, Jing Guo, Lan-Juan Li.   

Abstract

This study explored the effects of a classical Chinese medicine formula- Xiao-Chai-Hu Tang(XCHT) on the model mice with D-galactosamine -induced liver injury. Sixty male imprinting control region (ICR) mice were used in the present study, and they were separated randomly into 6 groups: a normal control group (Group A, n=10), a model control (Group B, n=10), a positive control (Group C, n=10), a low dose of XCHT group (Group D, n=10), a medium dose of XCHT group (Group E, n=10), and a high dose of XCHT group (Group F, n=10). ELISA was used to detect the IL-6 and TNF-α levels in the serum. Real-time PCR was performed to assess the expression of FasmRNA, Fas-LmRNA, Bcl-2mRNA of the liver tissues. Western blotting was used to detect the Bax protein expression of the liver tissues. The serum IL-6 and TNF-α levels of Group B were significantly higher than the other groups (P<0.05). The expression of Fas mRNA, Fas-LmRNA, and Bax protein of the liver tissues of Group B were significantly higher than those of the other groups (P<0.05). The expression of Bcl-2 mRNA of the liver tissues of Group B was significantly lower than other groups (P<0.05). Both of XCHT and biphenyl dicarboxylate significantly decreased the serum IL-6 and TNF-α levels and FasmRNA, FasLmRNA, Bax protein expression and increased the Bcl-2 mRNA expression of the liver tissues of model mice (P<0.05). It may be through decreasing the serum IL-6 and TNF-α levels and FasmRNA, FasLmRNA, Bax protein expression and increasing the Bcl-2 mRNA expression of the liver tissues that XCHT significantly relieved the D-galactosamine -induced liver injury.

Entities:  

Keywords:  Chinese medicine formula; Liver injury; Xiao-Chai-Hu Tang(XCHT)

Mesh:

Substances:

Year:  2012        PMID: 23983374      PMCID: PMC3746662          DOI: 10.4314/ajtcam.v9i3.16

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


  7 in total

1.  Change in tolbutamide permeability in rat jejunum and Caco-2 cells by Sho-saiko-to (Xiao Chai Hu Tang), a Chinese traditional medicine.

Authors:  Nobuhiro Nishimura; Tomichika Uemura; Kikuo Iwamoto; Kohji Naora
Journal:  J Pharm Pharmacol       Date:  2010-05       Impact factor: 3.765

2.  Modern use of Chinese herbal formulae from Shang-Han Lun.

Authors:  Fang-pey Chen; Fun-jou Chen; Maw-shiou Jong; Hui-lin Tsai; Jen-ren Wang; Shinn-jang Hwang
Journal:  Chin Med J (Engl)       Date:  2009-08-20       Impact factor: 2.628

3.  Effect of Sho-saiko-to extract on hepatic inflammation and fibrosis in dimethylnitrosamine induced liver injury rats.

Authors:  Masahiko Kusunose; Bing Qiu; Tailin Cui; Atsuhide Hamada; Saburo Yoshioka; Masahide Ono; Mitsuhiko Miyamura; Shojiro Kyotani; Yutaka Nishioka
Journal:  Biol Pharm Bull       Date:  2002-11       Impact factor: 2.233

4.  [Chronic active hepatitis with superinfection of delta virus and hepatitis B virus: treatment with Chinese traditional medicine].

Authors:  N L Chen; F Gu; K M Jia
Journal:  Zhonghua Nei Ke Za Zhi       Date:  1990-03

5.  [Controlled prospective trial to evaluate Syosakiko-to in preventing hepatocellular carcinoma in patients with cirrhosis of the liver].

Authors:  S Yamamoto; H Oka; T Kanno; Y Mizoguchi; K Kobayashi
Journal:  Gan To Kagaku Ryoho       Date:  1989-04

6.  Augmentation of NK activity after oral administration of a traditional Chinese medicine, xiao-chai-hu-tang (shosaiko-to).

Authors:  M Kaneko; T Kawakita; Y Tauchi; Y Saito; A Suzuki; K Nomoto
Journal:  Immunopharmacol Immunotoxicol       Date:  1994-02       Impact factor: 2.730

7.  Herbal medicine "sho-saiko-to" induces in vitro granulocyte colony-stimulating factor production on peripheral blood mononuclear cells.

Authors:  M Yamashiki; M Asakawa; Y Kayaba; Y Kosaka; A Nishimura
Journal:  J Clin Lab Immunol       Date:  1992
  7 in total
  4 in total

1.  Hepatoprotective Effect of Aqueous Extract from the Seeds of Orychophragmus violaceus against Liver Injury in Mice and HepG2 Cells.

Authors:  Xiaowei Huo; Chenqi Liu; Li Gao; Xudong Xu; Nailiang Zhu; Li Cao
Journal:  Int J Mol Sci       Date:  2017-06-15       Impact factor: 5.923

Review 2.  Preclinical Models for Investigation of Herbal Medicines in Liver Diseases: Update and Perspective.

Authors:  Hor-Yue Tan; Serban San-Marina; Ning Wang; Ming Hong; Sha Li; Lei Li; Fan Cheung; Xiao-Yan Wen; Yibin Feng
Journal:  Evid Based Complement Alternat Med       Date:  2016-01-28       Impact factor: 2.629

Review 3.  Drugs and Targets in Fibrosis.

Authors:  Xiaoyi Li; Lixin Zhu; Beibei Wang; Meifei Yuan; Ruixin Zhu
Journal:  Front Pharmacol       Date:  2017-11-23       Impact factor: 5.810

4.  Complex network model of the Treatise on Cold Damage Disorders.

Authors:  Feng-Jing Shao; Yi Sui; Yong-Hong Zhou; Ren-Cheng Sun
Journal:  Physica A       Date:  2016-04-08       Impact factor: 3.263

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.